Novo Nordisk A/S

Ladies and gentlemen, thank you for standing by and welcome to the first quarter 2020 Novo Nordisk Earnings Presentation Conference Call. At this time, all the participants are in a listen-only mode. After the speaker presentation, there will be a question and answer session. To ask a question during the session, you will need to press star one on your telephone. I must advise you that this call will be recorded today. I would now like to hand the conference over to your speaker today, Mr. Karsten Munk Knudsen. Please go ahead, sir.

Good. Thank you. Welcome to the virtual Q1 Nordisk London Roadshow. This is Karsten Munk Knudsen, CFO of Nordisk. With me today I have our CSO Mads Grossgaard-Thomsen and our EVP of Commercial Affairs and Commercial Strategy, Camilla Silvestre. So we have a broader presentation that we will go through briefly in the next 15 to 20 minutes after which we will move over to Q&A as in our normal London Q1 Roadshow launch events. First of all, I'd like to thank Michael Leuthen and UBS for hosting this virtual call. We hope you're all safe out there, even though it's challenging times with COVID-19. This is the agenda for today and as usual then this call might include some forward-looking statements and of course they are surrounded by uncertainty and I would say even or especially in these COVID-19 times there is a certain level of uncertainty regarding how that plays out and consequences of COVID-19.

In terms of COVID-19 and